Lupin Secures ANDA Approval, Set to Enter the Chinese Market
Indian global pharma giant on 22 May, though a press release has announced that the company has received the China's National Medical Products Administration’s (NMPA) approval of Abbreviated New Drug Application (ANDA) for its Oseltamivir...
Alembic Receives USFDA Approval for Levothyroxine Sodium Tablets
Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...
Commitment Towards Precise Diagnostic Services: Metropolis Healthcare Launches New Greenfield Laboratoryin Panjab
On 22nd May 2026, the Metropolis Healthcare, one of Indias leading diagnostics chain launches their new “Greenfield Laboratory” in Panjab’s Amritsar. The inauguration was graced by Dr. Anumeet Singh Grover, renowned gastroenterologist along with other renowned medical professionals across the country and...
Medicare Now Covers Obesity Drugs: Affordable GLP-1 Access Begins
In a landmark shift for American healthcare, Medicare has begun covering GLP-1 medications — including semaglutide (Wegovy) and tirzepatide(Zepbound) — for patients with obesity and related conditions,...
India’s CDSCO Bans Injectable Products From Being Marketed as Cosmetics
The Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, has issued a...
Sun Pharma Reports Strong Q4 with 26% Growth in Net Profit
Sun Pharmaceutical Industries Limited reported a strong fourth quarter for FY26, with consolidated net profit rising 26.2% year-on-year to ₹2,714 crore. Revenue for the quarter...